New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 23, 2013
14:42 EDTRDS.A, HBC, VOD, DEO, BPMoody's downgrades UK's government bond rating to Aa1 from Aaa
On Friday evening, Moody's Investors Service has downgraded the domestic- and foreign-currency government bond ratings of the United Kingdom by one notch to Aa1 from Aaa. The outlook on the ratings is now stable. The key interrelated drivers of today's action are: 1.The continuing weakness in the UK's medium-term growth outlook, with a period of sluggish growth which Moody's now expects will extend into the second half of the decade; 2.The challenges that subdued medium-term growth prospects pose to the government's fiscal consolidation programme, which will now extend well into the next parliament; 3. And, as a consequence of the UK's high and rising debt burden, a deterioration in the shock-absorption capacity of the government's balance sheet, which is unlikely to reverse before 2016.
News For A;DEO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 2, 2015
15:57 EDTALabCorp to offer PD-L1 companion diagnostic
Subscribe for More Information
15:43 EDTAQuest Diagnostics introduces Dako's PD-L1 companion diagnostic for KEYTRUDA
Subscribe for More Information
15:25 EDTAAgilent's Dako confirms FDA approval of NSCLC diagnostic
Dako, an Agilent Technologies (A) company and a worldwide provider of cancer diagnostics, announced the FDA approval of a new companion diagnostic assay that can reveal whether a patient with advanced non-small cell lung cancer, or NSCLC, is likely to respond to a new form of treatment. The approval of PD-L1 IHC 22C3 pharmDx strengthens Dako's portfolio of companion diagnostics and the company's leadership position in developing and commercializing companion diagnostic products. Dako developed PD-L1 IHC 22C3 pharmDx in partnership with Merck (MRK), maker of the anti-PD-1 therapy Keytruda. The FDA approved PD-L1 IHC 22C3 pharmDx for use in the United States. Dako hopes to gain regulatory approval for the new diagnostic in Canada, Europe and other jurisdictions next year.
September 30, 2015
17:04 EDTDEODiageo could be moving ahead with wine brands sale, Telegraph says
Diageo could be proceeding with its sale of its wine brands, including Blossom Hill, as the company sells off peripheral businesses, reports the Telegraph. Reference Link
11:48 EDTDEODiageo initiated with a Buy at UBS
Subscribe for More Information
September 27, 2015
13:46 EDTDEODiageo could return 25% in one year, Barron's says
Subscribe for More Information
September 24, 2015
17:04 EDTAMerck, Pfizer to collaborate with Agilent's Dako on Avelumab diagnostic
Subscribe for More Information
September 23, 2015
06:39 EDTDEODiageo: Currency weakness could impact demand for spirits in emerging markets
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use